Cryofreezing catheter ablation of adenosine triphosphate sensitive atrial tachycardia
Introduction Adenosine triphosphate (ATP) sensitive atrial tachycardia (AT) has been treated by radiofrequency catheter ablation. Cryofreezing energy has emerged as a novel energy source for catheter ablation. The aim of this study was to investigate the efficacy and safety of cryofreezing ablation...
Saved in:
| Published in: | Journal of cardiovascular electrophysiology Vol. 30; no. 4; pp. 528 - 537 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Wiley Subscription Services, Inc
01-04-2019
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Introduction
Adenosine triphosphate (ATP) sensitive atrial tachycardia (AT) has been treated by radiofrequency catheter ablation. Cryofreezing energy has emerged as a novel energy source for catheter ablation. The aim of this study was to investigate the efficacy and safety of cryofreezing ablation for ATP‐sensitive AT.
Methods and Results
A total of six patients with ATP‐sensitive ATs were included in this study. A single atrial extrastimulation was able to initiate and terminate these ATs in all six patients. The electrophysiological findings satisfied the diagnostic criteria of ATP‐sensitive AT. The ablation catheter was located at the earliest activation site of atrial excitation during the AT, and cryofreezing energy was delivered through a cryoablation catheter to perform cryomapping at temperature of −30 or −80°C. When cryomapping successfully terminated the ATs, cryoablation at a temperature of −80°C was subsequently performed. The earliest atrial activation during AT was recorded at the Koch's triangle area associated with a distinct intra‐atrial activation sequence from that recorded during ventricular pacing. Cryoablation was performed at successful cryomapping sites and resulted in the complete elimination of the AT in all six patients without affecting the bidirectional atrioventricular (AV) nodal conduction.
Conclusion
Cryofreezing energy was safe and effective in treating ATP‐sensitive ATs even in patients with its origins located in the vicinity of the AV node. |
|---|---|
| AbstractList | IntroductionAdenosine triphosphate (ATP) sensitive atrial tachycardia (AT) has been treated by radiofrequency catheter ablation. Cryofreezing energy has emerged as a novel energy source for catheter ablation. The aim of this study was to investigate the efficacy and safety of cryofreezing ablation for ATP‐sensitive AT.Methods and ResultsA total of six patients with ATP‐sensitive ATs were included in this study. A single atrial extrastimulation was able to initiate and terminate these ATs in all six patients. The electrophysiological findings satisfied the diagnostic criteria of ATP‐sensitive AT. The ablation catheter was located at the earliest activation site of atrial excitation during the AT, and cryofreezing energy was delivered through a cryoablation catheter to perform cryomapping at temperature of −30 or −80°C. When cryomapping successfully terminated the ATs, cryoablation at a temperature of −80°C was subsequently performed. The earliest atrial activation during AT was recorded at the Koch's triangle area associated with a distinct intra‐atrial activation sequence from that recorded during ventricular pacing. Cryoablation was performed at successful cryomapping sites and resulted in the complete elimination of the AT in all six patients without affecting the bidirectional atrioventricular (AV) nodal conduction.ConclusionCryofreezing energy was safe and effective in treating ATP‐sensitive ATs even in patients with its origins located in the vicinity of the AV node. INTRODUCTIONAdenosine triphosphate (ATP) sensitive atrial tachycardia (AT) has been treated by radiofrequency catheter ablation. Cryofreezing energy has emerged as a novel energy source for catheter ablation. The aim of this study was to investigate the efficacy and safety of cryofreezing ablation for ATP-sensitive AT. METHODS AND RESULTSA total of six patients with ATP-sensitive ATs were included in this study. A single atrial extrastimulation was able to initiate and terminate these ATs in all six patients. The electrophysiological findings satisfied the diagnostic criteria of ATP-sensitive AT. The ablation catheter was located at the earliest activation site of atrial excitation during the AT, and cryofreezing energy was delivered through a cryoablation catheter to perform cryomapping at temperature of -30 or -80°C. When cryomapping successfully terminated the ATs, cryoablation at a temperature of -80°C was subsequently performed. The earliest atrial activation during AT was recorded at the Koch's triangle area associated with a distinct intra-atrial activation sequence from that recorded during ventricular pacing. Cryoablation was performed at successful cryomapping sites and resulted in the complete elimination of the AT in all six patients without affecting the bidirectional atrioventricular (AV) nodal conduction. CONCLUSIONCryofreezing energy was safe and effective in treating ATP-sensitive ATs even in patients with its origins located in the vicinity of the AV node. Adenosine triphosphate (ATP) sensitive atrial tachycardia (AT) has been treated by radiofrequency catheter ablation. Cryofreezing energy has emerged as a novel energy source for catheter ablation. The aim of this study was to investigate the efficacy and safety of cryofreezing ablation for ATP-sensitive AT. A total of six patients with ATP-sensitive ATs were included in this study. A single atrial extra-stimulation was able to initiate and terminate these ATs in all six patients. The electrophysiological findings satisfied the diagnostic criteria of ATP-sensitive AT. The ablation catheter was located at the earliest activation site of atrial excitation during the AT, and cryofreezing energy was delivered through a cryoablation catheter to perform cryomapping at temperature of -30 or -80 ℃. When cryomapping successfully terminated the ATs, cryoablation at a temperature of -80℃ was subsequently performed. The earliest atrial activation during AT was recorded at the Koch's triangle area associated with a distinct intra-atrial activation sequence from that recorded during ventricular pacing. Cryoablation was performed at successful cryomapping sites and resulted in the complete elimination of the AT in all six patients without affecting the bi-directional atrioventricular (AV) nodal conduction. Cryofreezing energy was safe and effective in treating ATP-sensitive ATs even in patients with its origins located in the vicinity of the AV node. This article is protected by copyright. All rights reserved. Introduction Adenosine triphosphate (ATP) sensitive atrial tachycardia (AT) has been treated by radiofrequency catheter ablation. Cryofreezing energy has emerged as a novel energy source for catheter ablation. The aim of this study was to investigate the efficacy and safety of cryofreezing ablation for ATP‐sensitive AT. Methods and Results A total of six patients with ATP‐sensitive ATs were included in this study. A single atrial extrastimulation was able to initiate and terminate these ATs in all six patients. The electrophysiological findings satisfied the diagnostic criteria of ATP‐sensitive AT. The ablation catheter was located at the earliest activation site of atrial excitation during the AT, and cryofreezing energy was delivered through a cryoablation catheter to perform cryomapping at temperature of −30 or −80°C. When cryomapping successfully terminated the ATs, cryoablation at a temperature of −80°C was subsequently performed. The earliest atrial activation during AT was recorded at the Koch's triangle area associated with a distinct intra‐atrial activation sequence from that recorded during ventricular pacing. Cryoablation was performed at successful cryomapping sites and resulted in the complete elimination of the AT in all six patients without affecting the bidirectional atrioventricular (AV) nodal conduction. Conclusion Cryofreezing energy was safe and effective in treating ATP‐sensitive ATs even in patients with its origins located in the vicinity of the AV node. |
| Author | Hirao, Kenzo Hirao, Tatsuhiko Okishige, Kaoru Nakamura, Rena A. Yamauchi, Yasuteru Shigeta, Takatoshi Yoshida, Hiroshi Nishimura, Takuro Sasano, Tetsuo |
| Author_xml | – sequence: 1 givenname: Kaoru orcidid: 0000-0002-8202-9442 surname: Okishige fullname: Okishige, Kaoru email: okishige@yo.rim.or.jp organization: Heart Center, Japan Red Cross Yokohama City Bay Hospital – sequence: 2 givenname: Takatoshi orcidid: 0000-0003-1781-9218 surname: Shigeta fullname: Shigeta, Takatoshi organization: Heart Center, Japan Red Cross Yokohama City Bay Hospital – sequence: 3 givenname: Takuro orcidid: 0000-0002-0234-390X surname: Nishimura fullname: Nishimura, Takuro organization: Heart Center, Japan Red Cross Yokohama City Bay Hospital – sequence: 4 givenname: Rena A. surname: Nakamura fullname: Nakamura, Rena A. organization: Heart Center, Japan Red Cross Yokohama City Bay Hospital – sequence: 5 givenname: Tatsuhiko surname: Hirao fullname: Hirao, Tatsuhiko organization: Heart Center, Japan Red Cross Yokohama City Bay Hospital – sequence: 6 givenname: Hiroshi surname: Yoshida fullname: Yoshida, Hiroshi organization: Heart Center, Japan Red Cross Yokohama City Bay Hospital – sequence: 7 givenname: Yasuteru surname: Yamauchi fullname: Yamauchi, Yasuteru organization: Heart Center, Japan Red Cross Yokohama City Bay Hospital – sequence: 8 givenname: Tetsuo orcidid: 0000-0003-3582-6104 surname: Sasano fullname: Sasano, Tetsuo organization: Arrhythmia Center, Tokyo Medical and Dental University – sequence: 9 givenname: Kenzo surname: Hirao fullname: Hirao, Kenzo organization: Arrhythmia Center, Tokyo Medical and Dental University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30656771$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kE1LxDAQhoMofh_8A1Lwooe6SZM07VGW9QvBi57DNJ26WbrJmnSV9dcb3dWD4FxmGB7eGZ4Dsu28Q0JOGL1kqUYzg5eMV0JskX0mBc0rVqrtNFMhc14pvkcOYpxRynhJ5S7Z47SUpVJsnzyPw8p3AfHDupfMwDDFAUMGTQ-D9S7zXQYtOh-tw2wIdjH1cTGFAbOILtrBvmEGaQ99NoCZrgyE1sIR2emgj3i86Yfk-XryNL7NHx5v7sZXD7kRrBa5ZE0JVUFrUzaACjhgowpWmKJWDeedobySyjDeYCE7I6qircFUjHcNb41AfkjO17mL4F-XGAc9t9Fg34NDv4y6YKrmteSSJvTsDzrzy-DSd7pIJxUTvC4TdbGmTPAxBuz0Itg5hJVmVH-51sm1_nad2NNN4rKZY_tL_shNwGgNvNseV_8n6fvxZB35Cc7iiq4 |
| CitedBy_id | crossref_primary_10_1016_j_jjcc_2020_10_012 crossref_primary_10_1111_jce_13878 crossref_primary_10_1111_pace_14540 crossref_primary_10_1016_j_hrcr_2024_05_006 |
| Cites_doi | 10.1046/j.1540-8167.2002.01082.x 10.1016/j.hrcr.2018.08.003 10.1253/circj.CJ-12-1025 10.1136/hrt.79.6.616 10.1111/j.1540-8167.2005.50054.x 10.1016/j.hrthm.2005.08.030 10.1161/01.CIR.0000040587.73251.48 10.1007/s10840-006-9006-8 10.1007/s10840-014-9911-1 10.1016/j.hrthm.2012.05.012 10.1161/01.CIR.94.3.571 10.1016/S1880-4276(08)80030-0 10.1111/j.1540-8159.2006.00380.x 10.1161/01.RES.32.6.731 10.1093/europace/eur297 10.1093/europace/eup086 10.1111/j.1540-8167.1997.tb00846.x 10.1093/europace/eum145 10.1161/01.CIR.92.12.3490 10.1016/j.hrthm.2007.10.013 10.1161/01.CIR.68.3.644 10.1016/j.hrthm.2004.06.018 10.1111/j.1540-8159.2004.00651.x 10.1093/europace/eup310 10.1111/j.1540-8159.1998.tb00060.x 10.1016/j.jacc.2006.02.053 10.1016/j.hrcr.2017.03.001 10.1016/j.amjcard.2014.03.011 10.1111/pace.13117 10.1111/j.1540-8159.2008.01156.x 10.1093/europace/eup177 |
| ContentType | Journal Article |
| Copyright | 2019 Wiley Periodicals, Inc. This article is protected by copyright. All rights reserved. |
| Copyright_xml | – notice: 2019 Wiley Periodicals, Inc. – notice: This article is protected by copyright. All rights reserved. |
| DBID | NPM AAYXX CITATION 7QP K9. 7X8 |
| DOI | 10.1111/jce.13844 |
| DatabaseName | PubMed CrossRef Calcium & Calcified Tissue Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | PubMed CrossRef ProQuest Health & Medical Complete (Alumni) Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
| DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology Biology |
| EISSN | 1540-8167 |
| EndPage | 537 |
| ExternalDocumentID | 10_1111_jce_13844 30656771 JCE13844 |
| Genre | article Journal Article |
| GroupedDBID | --- .3N .GA .GJ .Y3 04C 05W 0R~ 10A 1OB 1OC 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOJX ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHEFC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMSDO BMXJE BPMNR BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F D-I DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBC EBD EBS ECF ECT ECV EIHBH EJD EMB EMK EMOBN ENC EPT ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 Q~Q R.K RIWAO ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K VVN W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQ9 WQJ WRC WUP WVDHM WXI WXSBR XG1 ZGI ZXP ZZTAW ~IA ~WT NPM AAMNL AAYXX CITATION 7QP K9. 7X8 |
| ID | FETCH-LOGICAL-c4194-51b6a8209c6bae7a3aeb7212c297b33fc03857c13be25fc482d9ac813fb3dc4e3 |
| IEDL.DBID | 33P |
| ISSN | 1045-3873 |
| IngestDate | Sat Aug 17 03:58:03 EDT 2024 Sun Nov 24 01:51:02 EST 2024 Thu Nov 21 22:08:30 EST 2024 Wed Oct 16 00:49:52 EDT 2024 Sat Aug 24 01:16:05 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | adenosine catheter ablation cryofreezing atrial tachycardia |
| Language | English |
| License | This article is protected by copyright. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4194-51b6a8209c6bae7a3aeb7212c297b33fc03857c13be25fc482d9ac813fb3dc4e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-8202-9442 0000-0002-0234-390X 0000-0003-1781-9218 0000-0003-3582-6104 |
| PMID | 30656771 |
| PQID | 2212714396 |
| PQPubID | 1086397 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_2179395350 proquest_journals_2212714396 crossref_primary_10_1111_jce_13844 pubmed_primary_30656771 wiley_primary_10_1111_jce_13844_JCE13844 |
| PublicationCentury | 2000 |
| PublicationDate | April 2019 |
| PublicationDateYYYYMMDD | 2019-04-01 |
| PublicationDate_xml | – month: 04 year: 2019 text: April 2019 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Hoboken |
| PublicationTitle | Journal of cardiovascular electrophysiology |
| PublicationTitleAlternate | J Cardiovasc Electrophysiol |
| PublicationYear | 2019 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | e_1_2_6_1_7_1 e_1_2_6_1_30_1 e_1_2_6_1_6_1 e_1_2_6_1_9_1 e_1_2_6_1_8_1 e_1_2_6_1_3_1 e_1_2_6_1_11_1 e_1_2_6_1_2_1 e_1_2_6_1_12_1 e_1_2_6_1_33_1 e_1_2_6_1_5_1 e_1_2_6_1_32_1 e_1_2_6_1_4_1 e_1_2_6_1_10_1 e_1_2_6_1_31_1 e_1_2_6_1_27_1 e_1_2_6_1_26_1 e_1_2_6_1_25_1 e_1_2_6_1_24_1 e_1_2_6_1_29_1 e_1_2_6_1_28_1 e_1_2_6_1_23_1 e_1_2_6_1_22_1 e_1_2_6_1_21_1 e_1_2_6_1_20_1 e_1_2_6_1_15_1 e_1_2_6_1_16_1 e_1_2_6_1_13_1 e_1_2_6_1_14_1 e_1_2_6_1_19_1 e_1_2_6_1_17_1 e_1_2_6_1_18_1 |
| References_xml | – ident: e_1_2_6_1_5_1 doi: 10.1046/j.1540-8167.2002.01082.x – ident: e_1_2_6_1_22_1 doi: 10.1016/j.hrcr.2018.08.003 – ident: e_1_2_6_1_21_1 doi: 10.1253/circj.CJ-12-1025 – ident: e_1_2_6_1_33_1 doi: 10.1136/hrt.79.6.616 – ident: e_1_2_6_1_9_1 doi: 10.1111/j.1540-8167.2005.50054.x – ident: e_1_2_6_1_20_1 doi: 10.1016/j.hrthm.2005.08.030 – ident: e_1_2_6_1_19_1 doi: 10.1161/01.CIR.0000040587.73251.48 – ident: e_1_2_6_1_26_1 doi: 10.1007/s10840-006-9006-8 – ident: e_1_2_6_1_10_1 doi: 10.1007/s10840-014-9911-1 – ident: e_1_2_6_1_30_1 doi: 10.1016/j.hrthm.2012.05.012 – ident: e_1_2_6_1_29_1 doi: 10.1161/01.CIR.94.3.571 – ident: e_1_2_6_1_27_1 doi: 10.1016/S1880-4276(08)80030-0 – ident: e_1_2_6_1_18_1 doi: 10.1111/j.1540-8159.2006.00380.x – ident: e_1_2_6_1_28_1 doi: 10.1161/01.RES.32.6.731 – ident: e_1_2_6_1_11_1 doi: 10.1093/europace/eur297 – ident: e_1_2_6_1_25_1 doi: 10.1093/europace/eup086 – ident: e_1_2_6_1_2_1 doi: 10.1111/j.1540-8167.1997.tb00846.x – ident: e_1_2_6_1_6_1 doi: 10.1093/europace/eum145 – ident: e_1_2_6_1_32_1 doi: 10.1161/01.CIR.92.12.3490 – ident: e_1_2_6_1_17_1 doi: 10.1016/j.hrthm.2007.10.013 – ident: e_1_2_6_1_14_1 – ident: e_1_2_6_1_12_1 doi: 10.1161/01.CIR.68.3.644 – ident: e_1_2_6_1_16_1 doi: 10.1016/j.hrthm.2004.06.018 – ident: e_1_2_6_1_4_1 doi: 10.1111/j.1540-8159.2004.00651.x – ident: e_1_2_6_1_15_1 doi: 10.1093/europace/eup310 – ident: e_1_2_6_1_3_1 doi: 10.1111/j.1540-8159.1998.tb00060.x – ident: e_1_2_6_1_23_1 doi: 10.1016/j.jacc.2006.02.053 – ident: e_1_2_6_1_24_1 doi: 10.1016/j.hrcr.2017.03.001 – ident: e_1_2_6_1_31_1 doi: 10.1016/j.amjcard.2014.03.011 – ident: e_1_2_6_1_13_1 doi: 10.1111/pace.13117 – ident: e_1_2_6_1_7_1 doi: 10.1111/j.1540-8159.2008.01156.x – ident: e_1_2_6_1_8_1 doi: 10.1093/europace/eup177 |
| SSID | ssj0013605 |
| Score | 2.3510864 |
| Snippet | Introduction
Adenosine triphosphate (ATP) sensitive atrial tachycardia (AT) has been treated by radiofrequency catheter ablation. Cryofreezing energy has... Adenosine triphosphate (ATP) sensitive atrial tachycardia (AT) has been treated by radiofrequency catheter ablation. Cryofreezing energy has emerged as a novel... IntroductionAdenosine triphosphate (ATP) sensitive atrial tachycardia (AT) has been treated by radiofrequency catheter ablation. Cryofreezing energy has... INTRODUCTIONAdenosine triphosphate (ATP) sensitive atrial tachycardia (AT) has been treated by radiofrequency catheter ablation. Cryofreezing energy has... |
| SourceID | proquest crossref pubmed wiley |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 528 |
| SubjectTerms | Ablation adenosine Adenosine triphosphate ATP atrial tachycardia Cardiac arrhythmia catheter ablation Catheters Conduction cryofreezing Electrocardiography Energy Medical instruments Patients Radio frequency Radiofrequency ablation Tachycardia Temperature Ventricle |
| Title | Cryofreezing catheter ablation of adenosine triphosphate sensitive atrial tachycardia |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjce.13844 https://www.ncbi.nlm.nih.gov/pubmed/30656771 https://www.proquest.com/docview/2212714396 https://search.proquest.com/docview/2179395350 |
| Volume | 30 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFD7oQPHFy-alOiWKiC-Vtekt-DTnxhAUQQe-lSRN2YvtWLeH-es9SdvpEEHwLdCUlJ5LvpNzzheAS9cR-u4AbnPqCwxQqLAjlXbskAUIZwM0KKkbhYcv4dNbdN_XNDm3dS9MyQ-xPHDTlmH8tTZwLorvRi7VjUMjT3OBYpRg2jfo81cGoeyJxGjD1_yxtGIVMlU89Zure9EPgLmKV82GM9j516fuwnaFM0m3VIw9WFNZE1rdDGPs9wW5Iqby0xypN2Hjrh5tPlap9haMetNFnk6V-sDNjRh2VxQB4aIsniN5SniimcZxNpmh6xnnxWSMyJUUuiZee1HCzZ0gZMbleCGNKu7DaNB_7Q3t6g4GW3oO82zfEQFHlMBkILgKOeVKYNDoSpeFgtJU6sxiKB0qlOun0ovchHEZOTQVNJGeogfQyPJMHQGhOsnqO9wVbsdLhRSpJ9CD8IQlGudHFlzU0ognJdVGvAxRpIrNH7SgXcsprqytiF1NU4_AjwUWnC8fo53o5AfPVD7HOdoTMZ_6HQsOS_kuV8GwyQ_C0LHg2ojx9-Xjh17fDI7_PvUEthBlsbLcpw2N2XSuTmG9SOZnRmU_Acjp7FU |
| link.rule.ids | 315,782,786,1408,27933,27934,46064,46488 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB7xEJQL5VUI0GJQhbgEbWLnYYkLXRYtFBBSQeotsh1HeyFZ7eOw_fWdcZItqKpUiZulOHKUefgbz8xngK9hoOnuAOUrHmkMULj2U1t0_ETGCGdjNChDjcL9H8nDz_SqRzQ5F20vTM0PMT9wI8tw_poMnA6kX1u5secBT4VYhGURoyJSAwd__JNDqLsiMd6IiEGWN7xCro6nffXtbvQXxHyLWN2Wc_3xfR-7AesN1GSXtW5swoItt2D7ssQw-2XGTpkr_nSn6luw8q0drd432fZteO6OZlUxsvYX7m_MEbyiFJjSdf0cqwqmciIbx9lsgt5nUI2HAwSvbExl8eRImXLXgrCJMoOZcdq4A8_Xvadu32-uYfCNCKTwo0DHCoGCNLFWNlFcWY1xY2hCmWjOC0PJxcQEXNswKoxIw1wqkwa80Dw3wvJPsFRWpd0DxinPGgUq1GFHFNroQmh0IiqXOUH91IOTVhzZsGbbyOZRirGZ-4MeHLaCyhqDG2chMdUj9pOxB8fzx2gqlP9Qpa2mOIeckYx41PFgtxbwfBWMnKI4SQIPzpwc_718dtvtucH-_089gg_9p_u77O7m4fsBrCHoknX1zyEsTUZT-xkWx_n0i9Pf37yc8H0 |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS-wwEB50RfFFPV7rNYocfKlsm_QSfNJ1F483BI9w3kqSJuyL7bKXh_XXO0nbVTkcOOBboCkpnczMN5mZLwCnYSDt3QHCFzSSGKBQ6afatP2ExwhnY1QoZRuFb56Txz_pddfS5Fw0vTAVP8TswM1qhrPXVsEHufms5EqfBzRlbB4WGMJwS5xP6dNHCqFqisRwI7IEsrSmFXJlPM2rX53RXwjzK2B1Hqe3-q1vXYOVGmiSy2pn_IA5XazDxmWBQfbrlPwkrvTTnamvw-JVM1p6qHPtG_DSGU5LM9T6Db0bcfSuKAMiZFU9R0pDRG6pxnE2GaPt6ZejQR-hKxnZonhrRolwl4KQsVD9qXJ7cRNeet3fnRu_voTBVyzgzI8CGQuECVzFUuhEUKElRo2hCnkiKTXKphYTFVCpw8goloY5FyoNqJE0V0zTLWgVZaF3gFCbZY0CEcqwzYxU0jCJJkTkPLdAP_XgpJFGNqi4NrJZjKJ05v6gB_uNnLJa3UZZaHnqEfnx2IPj2WNUFJv9EIUuJzjHmiIe0ajtwXYl39kqGDdFcZIEHpw5Mf57-ey203WD3f-fegRLT9e97P7X490eLCPi4lXpzz60xsOJPoD5UT45dLv3Hduo7yM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cryofreezing+catheter+ablation+of+adenosine+triphosphate+sensitive+atrial+tachycardia&rft.jtitle=Journal+of+cardiovascular+electrophysiology&rft.au=Okishige%2C+Kaoru&rft.au=Shigeta%2C+Takatoshi&rft.au=Nishimura%2C+Takuro&rft.au=Nakamura%2C+Rena+A.&rft.date=2019-04-01&rft.issn=1045-3873&rft.eissn=1540-8167&rft.volume=30&rft.issue=4&rft.spage=528&rft.epage=537&rft_id=info:doi/10.1111%2Fjce.13844&rft.externalDBID=10.1111%252Fjce.13844&rft.externalDocID=JCE13844 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1045-3873&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1045-3873&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1045-3873&client=summon |